登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRxiv，3月27日，Mechanical Ventilator Milano (MVM):A Novel Mechanical Ventilator Designed for Mass Scale Production in response to the COVID-19 Pandemics》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-28

  • Mechanical Ventilator Milano (MVM):A Novel Mechanical Ventilator Designed for Mass Scale Production in response to the COVID-19 Pandemics

    Galbiati Cristiano, Walter Bonivento, Mauro Caravati, Marco Razeti, Sandro DeCecco, Giuliana Fiorillo, Federico Gabriele, Roberto Tartaglia, Alessandro Razeto, Davide Sablone, Eugenio Scapparone, Gemma Testera, Marco Rescigno, Davide Franco, Iza Kochanek, Cary Kendziora, Stephen H. Pordes, Hanguo Wang, Andrea Ianni, Art McDonald, L. Molinari Tosatti, T. Dinon, M. Malosio, D. Minuzzo, A. Zardoni, A. Prini

    doi: https://doi.org/10.1101/2020.03.24.20042234

    Abstract

    We present here the design of the Mechanical Ventilator Milano (MVM), a novel mechan- ical ventilator designed for mass scale production in response to the COVID-19 pandemics, to compensate for the dramatic shortage of such ventilators in many countries. This venti- lator is an electro-mechanical equivalent of the old, reliable Manley Ventilator. Our design is optimized to permit large sale production in short time and at a limited cost, relying on off-the-shelf components, readily available worldwide from hardware suppliers. Operation of the MVM requires only a source of compressed oxygen (or compressed medical air) and electrical power.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.03.24.20042234v1
10浏览量
原文链接
相关报告

  • 《MedRxiv，5月3日，Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-05-04
    • Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics Christoph B. Messner, Vadim Demichev, Daniel Wendisch, Laura Michalick, Matthew White, Anja Freiwald, Kathrin Textoris-Taube, Spyros I. Vernardis, Anna-Sophia Egger, Marco Kreidl, Daniela Ludwig, Christiane Kilian, Federica Agostini, Aleksej Zelezniak, Charlotte Thibeault, Moritz Pfeiffer, Stefan Hippenstiel, Andreas Hocke, Christof von Kalle, Archie Campbell, Caroline Hayward, David J. Porteous, Riccardo E. Marioni, Claudia Langenberg, Kathryn S. Lilley, Wolfgang M. Kuebler, Michael Muelleder, Christian Drosten, Martin Witzenrath, Florian Kurth, Leif Erik Sander, View ORCID ProfileMarkus Ralser doi: https://doi.org/10.1101/2020.04.27.20081810 Abstract The COVID-19 pandemic is an unprecedented global challenge. Highly variable in its presentation, spread and clinical outcome, novel point-of-care diagnostic classifiers are urgently required. Here, we describe a set of COVID-19 clinical classifiers discovered using a newly designed low-cost high-throughput mass spectrometry-based platform. Introducing a new sample preparation pipeline coupled with short-gradient high-flow liquid chromatography and mass spectrometry, our methodology facilitates clinical implementation and increases sample throughput and quantification precision. Providing a rapid assessment of serum or plasma samples at scale, we report 27 biomarkers that distinguish mild and severe forms of COVID-19, of which some may have potential as therapeutic targets. These proteins highlight the role of complement factors, the coagulation system, inflammation modulators as well as pro-inflammatory signalling upstream and downstream of Interleukin 6. Application of novel methodologies hence transforms proteomics from a research tool into a rapid-response, clinically actionable technology adaptable to infectious outbreaks.
    50浏览量
    原文链接

  • 《MedRxiv，3月18日，Understanding Epidemic Data and Statistics: A case study of COVID-19》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-19
    • Understanding Epidemic Data and Statistics: A case study of COVID-19 Amirhoshang Hoseinpour Dehkordi, Majid Alizadeh, Pegah Derakhshan, Peyman Babazadeh, Arash Jahandideh doi: https://doi.org/10.1101/2020.03.15.20036418 Abstract The 2019-Novel-Coronavirus (COVID-19) has affected 115 countries and out of more than 118,000 confirmed cases. Understanding the transmission dynamics of the infection in each country which affected on a daily basis and evaluating the effectiveness of control policies is critical for our further actions. To date, the statistics of COVID-10 reported cases show more than 80 percent of infected had a mild case of disease, while around 14 percent of infected experienced a severe one and about 5 percent are categorized as critical disease victims. Today's report (2020-03-12; daily updates in the prepared website) shows the confirmed cases of COVID-19 in China, South Korea, Italy, and Iran are 80932, 7869, 12462 and 10075; respectively. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    109浏览量
    原文链接